Incyte Corporation (INCY)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 32,615 | 597,599 | 340,660 | 948,581 | -295,697 |
| Revenue | US$ in thousands | 4,241,220 | 3,693,100 | 3,394,640 | 2,986,270 | 2,666,700 |
| Net profit margin | 0.77% | 16.18% | 10.04% | 31.76% | -11.09% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $32,615K ÷ $4,241,220K
= 0.77%
Incyte Corporation's net profit margin has shown significant fluctuations over the past five years. As of December 31, 2020, the net profit margin was -11.09%, indicating that the company experienced a loss relative to its revenue. However, the margin improved drastically to 31.76% by December 31, 2021, reflecting a strong profitability performance.
Subsequently, the net profit margin decreased to 10.04% by December 31, 2022, suggesting a decline in the company's ability to translate sales into profits. It then rose to 16.18% by December 31, 2023, depicting a recovery in profitability. However, by December 31, 2024, the net profit margin dropped significantly to 0.77%, indicating a sharp decrease in profitability compared to the previous period.
Overall, Incyte Corporation's net profit margin has been volatile, with periods of both strong profitability and significant declines. It is essential for the company to closely monitor and manage its costs and revenue streams to sustain and improve its profitability in the future.
Peer comparison
Dec 31, 2024